How Boehringer Ingelheim Animal Health Streamlines Complex Research with Prelude

Background: Boehringer Ingelheim’s Long History of Clinical Innovation

For over 100 years, Boehringer Ingelheim has operated as a leading independent pharmaceutical company dedicated to developing innovative therapies to improve the well-being of both human patients and animals. Today, Boehringer Ingelheim serves over 130 markets in service of a more healthy and sustainable future.

When selecting an EDC partner for a recent full development, pharma-therapeutic clinical field trial study, Boehringer Ingelheim Animal Health partnered with Prelude to better accommodate their complex study design, simplify investigator data capture, and streamline clinical monitoring.

The Challenge: Reduce Study Timelines and Adapt to a Complex Protocol to Accelerate Impact

The Solution: An EDC Platform Built for Complex Research, Paired with Exemplar Customer Service

After thorough evaluation by the clinical study team and management, Boehringer selected Prelude’s EDC platform, sharing that “what influenced our decision was Prelude’s years of experience and their proven ability to handle complex study designs.”

The implementation utilized a wide range of Prelude’s capabilities, including:

• Client-built forms using Prelude’s self-service, no-code builder interface
• Prelude-built custom forms and templates
• Imported IRT “table-based” randomization
• Built-in adverse event (AE) and ConMed coding
• An integrated lab data interface
• Inventory and document management
• Site invoicing

Implementation Experience: Partnership from Day One

The onboarding process revealed Prelude’s commitment to understanding each study’s unique needs.

“There’s a genuine interest in what they’re building,” the Boehringer team shared. “They’ve read the protocol, are listening closely during meetings for our feedback, and are responding with valuable insight to what’s been built.”

The partnership model proved particularly effective because of:

• Responsive Prelude account management with quick responses to questions and requests
• Experienced Customer Success Engineers who served as product experts and were always available to help move the study forward
• Regular weekly meetings between Prelude’s customer success team and the Boehringer study team
• Direct communication across the team maintained from start to finish

When improvement opportunities arose, the Boehringer team shared that “Prelude has always been receptive to our suggestions and feedback.”

Results: Measurable Improvements Across Key Metrics

Adopting Prelude’s EDC platform delivered significant improvements across multiple important focus areas for the Boehringer Ingelheim team:

Quality & Compliance

• Higher standards in data management processes
• Reduced compliance risks through robust system architecture
• Better attributability for all data points

Operational Efficiency

• Expanded toolset for building out forms
• Wider ranges of form functionality compared to previous solutions
• Streamlined workflows reducing overall study management time

Stakeholder Satisfaction

• Appreciation from investigators for improved usability
• Increased site satisfaction from end users
• Gained trust from other stakeholders due to reliable system performance

What Sets Prelude Apart

In addition to the highly configurable platform and hands-on customer support, Boehringer Ingelheim’s team shared that they greatly valued “that the study team’s expectations are met with a fully functional EDC system. All features, modules, and extras are packaged together within a single sign-on of the EDC system.”

The integrated approach eliminates the complexity of managing multiple systems, providing a seamless experience for the study team and sites alike.

The Bottom Line

For organizations considering EDC options for complex research, Boehringer’s experience offers a clear recommendation:

“[Prelude’s] EDC system, working relationship, and their experience are what sets them apart.”

As Boehringer continues to innovate in service of human and animal well-being, Prelude seeks to remove barriers to cutting-edge complex research through its combination of technical capabilities, responsive partnership, and deep clinical expertise. With Prelude, Boehringer Ingelheim has found not just a technology solution, but a true partner committed to their success.